Evaxion Biotech A/S

NASDAQ: EVAX · Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT

Evaxion Biotech A/S Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3.34M 73K n/a n/a
Cost of Revenue
n/a 112.00 571.32K 343.45K
Gross Profit
3.34M 72.89K -571.32K -343.45K
Operating Income
-14.73M -22.2M -25.26M -25.83M
Interest Income
254K 154K 2.83M 2.04M
Pretax Income
-11.36M -22.91M -23.94M -24.71M
Net Income
-10.57M -22.13M -23.17M -24.53M
Selling & General & Admin
7.32M 10.35M 8.21M 6.25M
Research & Development
10.46M 11.92M 17.06M 19.58M
Other Expenses
302K n/a n/a n/a
Operating Expenses
18.08M 22.25M 25.26M 25.83M
Interest Expense
962K 897K 1.51M 915K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
18.08M 22.27M 25.26M 25.83M
Income Tax Expense
-788K -791.22K -772K -178K
Shares Outstanding (Basic)
1.07M 683.39K 590.97K 487.33K
Shares Outstanding (Diluted)
1.07M 683.39K 590.97K 487.33K
EPS (Basic)
-10 -32.44 -39.2 -50.32
EPS (Diluted)
-10 -32.44 -39.2 -50.32
EBITDA
-9.77M -21.4M -22.58M -24.17M
EBIT
-10.39M -22.02M -23.16M -24.51M
Depreciation & Amortization
607.02K 615.95K 571.32K 343.45K